127 related articles for article (PubMed ID: 32525024)
21. Prognostic Analysis of Hepatocellular Carcinoma With Hepatitis C Virus Infection Using Epithelial-Mesenchymal Transition Gene Profiles.
Ueno M; Kawai M; Park JY; Hirono S; Okada KI; Hayami S; Wang HJ; Yamaue H
J Surg Res; 2020 Jan; 245():302-308. PubMed ID: 31421377
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B- and C-related hepatocellular carcinomas yield different clinical features and prognosis.
Chen CH; Huang GT; Yang PM; Chen PJ; Lai MY; Chen DS; Wang JD; Sheu JC
Eur J Cancer; 2006 Oct; 42(15):2524-9. PubMed ID: 16920352
[TBL] [Abstract][Full Text] [Related]
23. Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.
Huang YC; Huang CF; Chang KC; Hung SF; Wang JH; Hung CH; Chen CH; Tseng PL; Kee KM; Yen YH; Tsai PS; Tsai CC; Lu SN
J Gastroenterol Hepatol; 2011 Jan; 26(1):129-34. PubMed ID: 21175806
[TBL] [Abstract][Full Text] [Related]
24. Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.
Tornesello ML; Buonaguro L; Izzo F; Buonaguro FM
Oncotarget; 2016 May; 7(18):25087-102. PubMed ID: 26943571
[TBL] [Abstract][Full Text] [Related]
25. Identification of prognostic alternative splicing events related to the immune microenvironment of hepatocellular carcinoma.
Yu S; Cai L; Liu C; Gu R; Cai L; Zhuo L
Mol Med; 2021 Apr; 27(1):36. PubMed ID: 33832428
[TBL] [Abstract][Full Text] [Related]
26. Genome-Wide Profiling of Alternative Splicing Signatures Associated with Prognosis and Immune Microenvironment of Hepatocellular Carcinoma.
Liu Z; Ye J; Khan AA; Chen J; Zhou L; Zheng S; Xu X
Med Sci Monit; 2021 Aug; 27():e930052. PubMed ID: 34407065
[TBL] [Abstract][Full Text] [Related]
27. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
28. Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis.
Luo X; Wang Y; Shen A; Deng H; Ye M
BMC Med Genet; 2019 Aug; 20(1):142. PubMed ID: 31419949
[TBL] [Abstract][Full Text] [Related]
29. P21WAF1/CIP1 messenger RNA expression in hepatitis B, C virus-infected human hepatocellular carcinoma tissues.
Kobayashi S; Matsushita K; Saigo K; Urashima T; Asano T; Hayashi H; Ochiai T
Cancer; 2001 Jun; 91(11):2096-103. PubMed ID: 11391590
[TBL] [Abstract][Full Text] [Related]
30. Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma.
Huang R; Yan G; Sun H; Zhang J; Song D; Kong R; Yan P; Hu P; Xie A; Wang S; Zhuang J; Yin H; Meng T; Huang Z
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32627826
[TBL] [Abstract][Full Text] [Related]
31. Differences in prognostic factors according to viral status in patients with hepatocellular carcinoma.
Akahoshi H; Taura N; Ichikawa T; Miyaaki H; Akiyama M; Miuma S; Ozawa E; Takeshita S; Muraoka T; Matsuzaki T; Ohtani M; Isomoto H; Matsumoto T; Takeshima F; Nakao K
Oncol Rep; 2010 May; 23(5):1317-23. PubMed ID: 20372846
[TBL] [Abstract][Full Text] [Related]
32. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
33. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
34. Minor role of hepatitis B and C virus infection in the etiology of hepatocellular carcinoma in a low-endemic area.
Kaczynski J; Hansson G; Hermodsson S; Olsson R; Wallerstedt S
Scand J Gastroenterol; 1996 Aug; 31(8):809-13. PubMed ID: 8858752
[TBL] [Abstract][Full Text] [Related]
35. Lack of influence of cyclooxygenese-2 expression in hepatocellular carcinomas on patient survival.
Yildirim Y; Ozyilkan O; Bilezikci B; Akcali Z; Haberal M
Asian Pac J Cancer Prev; 2008; 9(2):295-8. PubMed ID: 18712978
[TBL] [Abstract][Full Text] [Related]
36. Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma.
Chen MF; Jeng LB; Lee WC; Chen TC
Surgery; 1998 May; 123(5):554-9. PubMed ID: 9591008
[TBL] [Abstract][Full Text] [Related]
37. Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection.
Huo TI; Wu JC; Lui WY; Lee PC; Huang YH; Chau GY; Tsay SH; Chang FY; Lee SD
Eur J Gastroenterol Hepatol; 2003 Nov; 15(11):1203-8. PubMed ID: 14560154
[TBL] [Abstract][Full Text] [Related]
38. Etiological and molecular profile of hepatocellular cancer from India.
Asim M; Sarma MP; Kar P
Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
[TBL] [Abstract][Full Text] [Related]
39. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
[TBL] [Abstract][Full Text] [Related]
40. Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors.
Jin YJ; Byun S; Han S; Chamberlin J; Kim D; Kim MJ; Lee Y
BMC Med Genomics; 2019 Dec; 12(Suppl 8):175. PubMed ID: 31856847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
